The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: N acetyl cysteine Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: Linezolid 600 mg Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: N acetyl cysteine Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: Linezolid 600 mg Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: N acetyl cysteine Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: Linezolid 600 mg Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: N acetyl cysteine Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: Linezolid 600 mg Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: N acetyl cysteine Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: Linezolid 600 mg Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: N acetyl cysteine Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition: Thrombocytopenia; Drugs Intervention: Drug: Linezolid 600 mg Sponsor: Helwan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials
The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition: Linezolid Induced Thrombocytopenia Intervention: Drug: N acetyl cysteine Sponsor: Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials